H. G. Olbrich

895 total citations
31 papers, 612 citations indexed

About

H. G. Olbrich is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Transplantation. According to data from OpenAlex, H. G. Olbrich has authored 31 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 15 papers in Surgery and 5 papers in Transplantation. Recurrent topics in H. G. Olbrich's work include Transplantation: Methods and Outcomes (13 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Acute Myocardial Infarction Research (5 papers). H. G. Olbrich is often cited by papers focused on Transplantation: Methods and Outcomes (13 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Acute Myocardial Infarction Research (5 papers). H. G. Olbrich collaborates with scholars based in Germany, Belgium and United States. H. G. Olbrich's co-authors include Sebastian K.G. Maier, Karl Heinrich Scholz, Claudius Jacobshagen, Jens Jung, Lars S. Maier, Gerald S. Werner, Tim Friede, Thomas Meyer, Björn Lengenfelder and Rainer Ott and has published in prestigious journals such as Journal of the American College of Cardiology, European Heart Journal and Transplantation.

In The Last Decade

H. G. Olbrich

30 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. G. Olbrich Germany 12 376 232 150 137 60 31 612
Henry Ooi United States 12 292 0.8× 170 0.7× 42 0.3× 106 0.8× 34 0.6× 25 622
Joseph M. Arcidi United States 16 553 1.5× 504 2.2× 29 0.2× 79 0.6× 67 1.1× 25 1.0k
Gregg M. Lanier United States 16 352 0.9× 339 1.5× 171 1.1× 270 2.0× 32 0.5× 82 707
Yedael Har‐Zahav Israel 15 476 1.3× 305 1.3× 59 0.4× 60 0.4× 259 4.3× 32 666
Raquel Marzoa‐Rivas Spain 15 193 0.5× 240 1.0× 37 0.2× 68 0.5× 34 0.6× 31 476
Sunit‐Preet Chaudhry United States 12 285 0.8× 227 1.0× 98 0.7× 209 1.5× 11 0.2× 42 562
M Röthlin Switzerland 15 353 0.9× 338 1.5× 27 0.2× 31 0.2× 43 0.7× 108 717
Sai Bhagra United Kingdom 12 547 1.5× 209 0.9× 36 0.2× 106 0.8× 28 0.5× 41 756
Shafiq Rehman United States 12 496 1.3× 167 0.7× 29 0.2× 66 0.5× 41 0.7× 27 747
Webb Wr United States 14 69 0.2× 236 1.0× 78 0.5× 58 0.4× 35 0.6× 55 538

Countries citing papers authored by H. G. Olbrich

Since Specialization
Citations

This map shows the geographic impact of H. G. Olbrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. G. Olbrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. G. Olbrich more than expected).

Fields of papers citing papers by H. G. Olbrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. G. Olbrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. G. Olbrich. The network helps show where H. G. Olbrich may publish in the future.

Co-authorship network of co-authors of H. G. Olbrich

This figure shows the co-authorship network connecting the top 25 collaborators of H. G. Olbrich. A scholar is included among the top collaborators of H. G. Olbrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. G. Olbrich. H. G. Olbrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scholz, Karl Heinrich, Björn Lengenfelder, Claudius Jacobshagen, et al.. (2020). Long-term effects of a standardized feedback-driven quality improvement program for timely reperfusion therapy in regional STEMI care networks. European Heart Journal Acute Cardiovascular Care. 10(4). 397–405. 11 indexed citations
2.
Scholz, Karl Heinrich, Tim Friede, Thomas Meyer, et al.. (2018). Prognostic significance of emergency department bypass in stable and unstable patients with ST-segment elevation myocardial infarction. European Heart Journal Acute Cardiovascular Care. 9(1_suppl). 34–44. 8 indexed citations
3.
Fengler, Karl, Georg Fuernau, Steffen Desch, et al.. (2014). GENDER DIFFERENCES IN PATIENTS WITH CARDIOGENIC SHOCK COMPLICATING MYOCARDIAL INFARCTION: A SUBSTUDY OF THE IABP-SHOCK II-TRIAL. Journal of the American College of Cardiology. 63(12). A720–A720. 5 indexed citations
4.
Scholz, Karl Heinrich, Sebastian K.G. Maier, Jens Jung, et al.. (2012). Reduction in Treatment Times Through Formalized Data Feedback. JACC: Cardiovascular Interventions. 5(8). 848–857. 34 indexed citations
5.
Nowak, Bernd, Björn Misselwitz, Arife Erdoğan, et al.. (2009). Do gender differences exist in pacemaker implantation?--results of an obligatory external quality control program. EP Europace. 12(2). 210–215. 88 indexed citations
6.
Richter, Markus, et al.. (2004). Reduction of ICAM-1 and LFA-1-positive leukocytes in the perivascular space of arteries under mycophenolate mofetil therapy reduces rat heart transplant vasculopathy. The Journal of Heart and Lung Transplantation. 23(12). 1405–1413. 8 indexed citations
7.
Richter, Markus, et al.. (2002). Cyclosporine does not enhance the development of accelerated coronary artery disease: experimental study in a rat cardiac transplant model. The Journal of Heart and Lung Transplantation. 21(4). 425–434. 5 indexed citations
8.
Richter, Markus, et al.. (2002). Cyclosporin a does not enhance the development of transplant vasculopathy: experimental study in a rat cardiac transplant model. Transplantation Proceedings. 34(5). 1479–1480. 2 indexed citations
9.
Richter, M., et al.. (2001). Do vascular compartments differ in the development of chronic rejection? AT1 blocker candesartan versus Ace blocker enalapril in an experimental heart transplant model. The Journal of Heart and Lung Transplantation. 20(10). 1092–1098. 7 indexed citations
10.
Richter, Markus, et al.. (2001). The impact of CD4 and CD8 transendothelial migration in the development of transplant arteriosclerosis following experimental cardiac transplantation. The Journal of Heart and Lung Transplantation. 20(2). 228–228. 1 indexed citations
11.
Mutschler, E., et al.. (2000). Vitamins C and E protect isolated cardiomyocytes against oxidative damage. International Journal of Cardiology. 75(2-3). 275–281. 32 indexed citations
12.
Richter, Markus, et al.. (1999). TCV-116 reduces chronic rejection in a rat heterotopic cardiac transplant model. Transplantation Proceedings. 31(1-2). 106–107. 7 indexed citations
13.
Weis, Michael, et al.. (1998). PROGNOSTIC SIGNIFICANCE OF CORONARY FLOW RESERVE ON LEFT VENTRICULAR EJECTION FRACTION IN CARDIAC TRANSPLANT RECIPIENTS. Transplantation. 65(1). 103–108. 43 indexed citations
14.
Hartmann, Andreas, Michael Weis, H. G. Olbrich, et al.. (1994). Endothelium-dependent and endothelium-independent vasomotion in large coronary arteries and in the microcirculation after cardiac transplantation. European Heart Journal. 15(11). 1486–1493. 21 indexed citations
15.
Olbrich, H. G., G Vandeplassche, Μ. Borgers, et al.. (1993). Ultrastructural calcium distribution and myocardial calcium content in human idiopathic dilated cardiomyopathy. Cardiovascular Pathology. 2(2). 127–136. 4 indexed citations
16.
Olbrich, H. G., Hugo Geerts, Luc Ver Donck, Gisbert Kober, & M. Kaltenbach. (1991). Cyclosporine A increases the intracellular free calcium concentration in electrically paced isolated rat cardiomyocytes. Journal of the American College of Cardiology. 17(2). A140–A140. 3 indexed citations
17.
Kloke, Marianne, K. Höffken, H. G. Olbrich, & Christin Schmidt. (1991). Anti-Depressants and Anti-Convulsants for the Treatment of Neuropathic Pain Syndromes in Cancer Patients. Oncology Research and Treatment. 14(1). 40–43. 15 indexed citations
18.
Olbrich, H. G., Hugo Geerts, E. Mutschler, et al.. (1991). THE EFFECT OF CYCLOSPORINE ON ELECTRICALLY PACED ISOLATED RAT CARDIOMYOCYTES. Transplantation. 51(5). 972–976. 11 indexed citations
19.
Donck, Luc Ver, Luc Wouters, H. G. Olbrich, E. Mutschler, & Μ. Borgers. (1991). Nebivolol Increases Survival in Cardiomyopathic Hamsters with Congestive Heart Failure. Journal of Cardiovascular Pharmacology. 18(1). 1–3. 16 indexed citations
20.
Zeuzem, Stefan, H. G. Olbrich, T Haak, & E Jungmann. (1990). In vivo evidence that human atrial natriuretic factor-(99–126) (hANF) stimulates parasympathetic activity in man. European Journal of Clinical Pharmacology. 39(1). 77–79. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026